Cancer Family
Sarcoma
CI-CAN-00000344SARExplore in graph →
635 active trials17 approved drugs182 evidence items
- NCIt
- C9118
- OncoTree
- SARCNOS
- DOID
- 1115
- MeSH
- D012509
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000344SARExplore in graph →
Clinical trials
2,688 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (367)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03420014 | Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)(FIBROSARC US) | unknown | Phase 2 | 114 | Philogen S.p.A.INDUSTRY | 1 | Oct 10, 2023 | clinicaltrials |
| NCT06076070 | GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers(PROGEN_SARC) | unknown | — | 10 | Regina Elena Cancer InstituteOTHER |
| 1 |
| Oct 10, 2023 |
| clinicaltrials |
| NCT05329792 | L19IL2/L19TNF in Skin Cancer Patients(IntriNSiC) | unknown | Phase 2 | 70 | Philogen S.p.A.INDUSTRY | 3 | Oct 6, 2023 | clinicaltrials |
| NCT03108677 | Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma | unknown | — | 90 | Ruijin HospitalOTHER | 1 | Oct 3, 2023 | clinicaltrials |
| NCT05448820 | YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma | unknown | Phase 1 / Phase 2 | 15 | Tracon Pharmaceuticals Inc.INDUSTRY | 1 | Sep 21, 2023 | clinicaltrials |
| NCT02495311 | The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms | unknown | — | 150 | Far Eastern Memorial HospitalOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT04311073 | Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies | unknown | Phase 3 | 50 | Eastern Virginia Medical SchoolOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT06020924 | The Effects of Uterine Fibroids on Pregnancy in Women | unknown | — | 1,658 | Wenwen WangOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT04741438 | Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype(RAR-Immune) | unknown | Phase 3 | 96 | Centre Leon BerardOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT06009562 | Management of Symptomatic Uterine Fibroids in Pregnancy by Laparotomic Myomectomy: a Prospective Cohort Study(LPTM-UFs-P) | unknown | — | 28 | University of PalermoOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT04735289 | Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma(Metabol-Sarc) | unknown | — | 810 | Istituto Ortopedico RizzoliOTHER | 1 | Aug 4, 2023 | clinicaltrials |
| NCT04510714 | BORIS - aBlação pOR mIcro-ondaS [Microwave Ablation](BORIS) | unknown | N/A | 60 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT05266196 | A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) | unknown | Phase 1 / Phase 2 | 10 | Salarius Pharmaceuticals, LLCINDUSTRY | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05078307 | Evaluation of a Hysteroscopic Method With Vaporization in the Hysteroscopic Treatment of Submucosal Uterine Fibroids(VAPOHYSTERO) | unknown | N/A | 54 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05961111 | A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05963035 | Clinical Application of 18F-PFPN PET Imaging in Diagnosis and Staging of Clear Cell Sarcoma of Soft Tissue | unknown | N/A | 10 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05952128 | Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma | unknown | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Jul 19, 2023 | clinicaltrials |
| NCT05886075 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors | unknown | Early Phase 1 | 24 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jun 2, 2023 | clinicaltrials |
| NCT05881967 | Molecular Mechanism Study of Uterine Sarcoma | unknown | — | 300 | Shixuan WangOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05442333 | Adjuvant Versus Neo-adjuvant Radiotherapy in Patients With Resectable Soft Tissue Sarcoma in Extremities : Wound Complications | unknown | N/A | 20 | Ain Shams UniversityOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT05860374 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | May 16, 2023 | clinicaltrials |
| NCT05851456 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | May 9, 2023 | clinicaltrials |
| NCT04240262 | Microwave Ablation for Leiomyoma(MYOMIC2) | unknown | — | 200 | Karolinska InstitutetOTHER | 1 | May 1, 2023 | clinicaltrials |
| NCT04318964 | TAEST16001 in the Treatment of Soft Tissue Sarcoma | unknown | Phase 1 | 12 | Sun Yat-sen UniversityOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05695690 | Role of US in Uterine Fibroids in Comparison With MRI Using FIGO Classification | unknown | — | 43 | Assiut UniversityOTHER | 0 | Apr 11, 2023 | clinicaltrials |
| NCT03985722 | Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma Patients(OLATRASTS) | unknown | Phase 1 | 28 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT04138381 | Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)(SeliGIST) | unknown | Phase 1 / Phase 2 | 30 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT05131386 | Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas(SYNERGIAS) | unknown | Phase 2 | 85 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT05778955 | Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma | unknown | — | 40 | Sun Yat-sen UniversityOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT05620355 | Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids. | unknown | Phase 3 | 312 | Bio Genuine (Shanghai) Biotech Co., Ltd.INDUSTRY | 1 | Mar 21, 2023 | clinicaltrials |
| NCT05548179 | Exploring Clinical Trial Experiences of People With Leiomyosarcoma | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Mar 6, 2023 | clinicaltrials |
| NCT03475953 | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors(REGOMUNE) | unknown | Phase 1 / Phase 2 | 747 | Institut BergoniéOTHER | 1 | Mar 3, 2023 | clinicaltrials |
| NCT02359474 | Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin(HyperTET) | unknown | Phase 2 | 120 | Ludwig-Maximilians - University of MunichOTHER | 1 | Feb 28, 2023 | clinicaltrials |
| NCT05747521 | Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma | unknown | N/A | 85 | Henan Cancer HospitalOTHER_GOV | 1 | Feb 28, 2023 | clinicaltrials |
| NCT05741671 | Sonographic Features of Fibroids Before and During Non-surgical Therapy and/or Expectant Management(MYOVASC) | unknown | — | 760 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT05739084 | Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STS(RADIOSARC) | unknown | — | 300 | Centre Leon BerardOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT05193188 | A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma | unknown | Phase 2 | 70 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Feb 16, 2023 | clinicaltrials |
| NCT05708391 | Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children | unknown | Phase 2 | 53 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Feb 1, 2023 | clinicaltrials |
| NCT03775525 | Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer(GEN602) | unknown | Phase 1 | 127 | Genzada Pharmaceuticals USA, Inc.INDUSTRY | 1 | Dec 23, 2022 | clinicaltrials |
| NCT05656144 | Cadonilimab in the Treatment of Advanced Soft Tissue Sarcoma | unknown | Phase 2 | 49 | Peking University Cancer Hospital & InstituteOTHER | 0 | Dec 19, 2022 | clinicaltrials |
| NCT05415098 | Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas | unknown | Phase 1 | 90 | Ascentage Pharma Group Inc.INDUSTRY | 1 | Nov 16, 2022 | clinicaltrials |
| NCT05614375 | Endoscopic Surgery in the Treatment of Soft Tissue Sarcoma in Nasal and Paranasal Sinus | unknown | — | 40 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Nov 14, 2022 | clinicaltrials |
| NCT05602415 | Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma | unknown | Phase 2 | 41 | Ruijin HospitalOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05602792 | A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 233 | ImmVira Pharma Co. LtdINDUSTRY | 1 | Nov 2, 2022 | clinicaltrials |
| NCT03359005 | Irinotecan and Temozolomide for Ewing Sarcoma | unknown | Phase 2 | 60 | Peking University People's HospitalOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT05596565 | The Effects of Observer Presence and Type on Patients' Perception of Exercise in Patients With Soft Tissue Sarcoma | unknown | N/A | 30 | Istanbul Medeniyet UniversityOTHER | 1 | Oct 27, 2022 | clinicaltrials |
| NCT04012827 | Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma | unknown | Phase 2 | 108 | Sun Yat-sen UniversityOTHER | 1 | Sep 7, 2022 | clinicaltrials |
| NCT05518526 | Phase 1b/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects With Previously Treated Soft-Tissue Sarcomas (STS) With Pulmonary Metastases(ANNA-SARC) | unknown | Phase 1 / Phase 2 | 64 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Aug 26, 2022 | clinicaltrials |
| NCT04960332 | Effect of Negative Pressure Wound Therapy After Surgical Removal of Deep-Seated High-Malignant Soft Tissue Sarcomas of the Extremities and Trunk Wall. | unknown | N/A | 160 | Rigshospitalet, DenmarkOTHER | 1 | Jul 6, 2022 | clinicaltrials |
| NCT01831609 | Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer | unknown | — | 1,000 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Oct 10, 2023source: clinicaltrials